Devaki Shilpa Surasi, MD
Nuclear Medicine · Houston, TXNPI 1538455811
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $5,444 of the $7,186 with a category attached, or 75.8%. 7 manufacturers reported payments, led by Amgen at 39.7% of the total. 2025 is the largest year on record at $6,606, more than ten times the $32 reported in 2022.
Across 18 payments — averaging $399.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$3K
- Novartis$3K
- Telix Pharmaceuticals$904
- GE HealthCare$323
- Blue Earth Diagnostics$144
- Johnson & Johnson$135
- plus $125 from 1 others
Across 8 payments — averaging $16,465 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Blue Earth Diagnostics$132K
What the payments were for
- Consulting fees$5,44476%
- Travel & lodging$2373%
- Food & beverage$1,50521%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 2 | $2,854 |
| Novartis | 1 | $2,700 |
| Telix Pharmaceuticals | 9 | $904 |
| GE HealthCare | 2 | $323 |
| Blue Earth Diagnostics | 2 | $144 |
| Johnson & Johnson | 1 | $135 |
| Elekta, Inc. | 1 | $125 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,186 in reported general payments places this provider in the 85th percentile of 37 nuclear medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nuclear medicine in Houston
- Warren MooreHouston$13K
- Beth ChasenHouston$12K
- Lesley FlyntHouston$8K
- Yang LuHouston$3K
- Simone KrebsHouston$3K
- Guofan XuHouston$878
- Patrick FordHouston$370
- Hubert ChuangHouston$263
- Nghi NguyenHouston$187
- Daniel LeeHouston$167
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.